Cencora (COR) Cash from Financing Activities (2009 - 2026)
Cencora's (COR) quarterly Cash from Financing Activities came in at $4.0 billion in Q1 2026, up 909.08% YoY from $394.3 million in Q1 2025, and up 9108.79% on a QoQ basis from $43.2 million in Q4 2025.
Cencora (COR) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Cencora (COR) has 18 years of Cash from Financing Activities data on file, last reported at $4.0 billion in Q1 2026.
- Quarterly Cash from Financing Activities rose 909.08% year-over-year to $4.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 billion (up 477.88% YoY) and the FY2025 annual result came in at $2.2 billion, up 196.49% from the prior year.
- Cash from Financing Activities climbed to $4.0 billion in Q1 2026, from $43.2 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $4.0 billion in Q1 2026 to a low of -$1.1 billion in Q2 2024.
- A 5-year average of $4.2 million and a median of -$491.7 million in 2025 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities plunged 1298.79% — and 2026, when it surged 909.08%.
- Tracing COR's Cash from Financing Activities over 5 years: stood at -$963.9 million in 2022, then surged by 42.77% to -$551.7 million in 2023, then surged by 681.72% to $3.2 billion in 2024, then slumped by 98.65% to $43.2 million in 2025, then soared by 9108.79% to $4.0 billion in 2026.
- The last three Cash from Financing Activities figures came in at $4.0 billion (Q1 2026), $43.2 million (Q4 2025), and -$683.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 1.63 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | -1.77 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | -490.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | -168.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 11.77 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -271.98 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -17.69 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 1.79 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.77 Bn |
| Jun 30, 2026 | -1.77 Bn |
| Mar 31, 2026 | 3.98 Bn |
| Mar 31, 2026 | 3.98 Bn |
| Dec 31, 2025 | 43.20 Mn |
| Dec 31, 2025 | 43.20 Mn |
| Sep 30, 2025 | -683.78 Mn |
| Sep 30, 2025 | -683.78 Mn |
| Jun 30, 2025 | 215.48 Mn |
| Jun 30, 2025 | 215.48 Mn |
| Mar 31, 2025 | -491.74 Mn |
| Mar 31, 2025 | -491.74 Mn |
| Dec 31, 2024 | 3.21 Bn |
| Dec 31, 2024 | 3.21 Bn |
| Sep 30, 2024 | -957.26 Mn |
| Sep 30, 2024 | -957.26 Mn |
| Jun 30, 2024 | -1.15 Bn |
| Jun 30, 2024 | -1.15 Bn |
| Mar 31, 2024 | 323.17 Mn |
| Mar 31, 2024 | 323.17 Mn |